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ABSTRACT
Objective To determine whether resting and exercise
electrocardiograms (ECGs) provide prognostic value that
is incremental to that obtained from the clinical history in
ambulatory patients with suspected angina attending
chest pain clinics.
Design Multicentre cohort study.
Setting Rapid access chest pain clinics of six hospitals in
England.
Participants 8176 consecutive patients with suspected
angina and no previous diagnosis of coronary artery
disease, all of whom had a resting ECG recorded. 4848
patients with a summary exercise ECG result recorded
(positive, negative, equivocal for ischaemia) comprised
the summary ECG subset of whom 1422 with more
detailed exercise ECG data recorded comprised the
detailed ECG subset.
Main outcome measure Composite of death due to
coronary heart disease or non-fatal acute coronary
syndrome during median follow-up of 2.46 years.
Results Receiver operating characteristics curves for the
basic clinical assessment model alone and with the
results of resting ECGs were superimposed with little
difference in the C statistic. With the exercise ECGs the C
statistic in the summary ECG subset increased from 0.70
(95% confidence interval 0.68 to 0.73) to 0.74 (0.71 to
0.76) and in the detailed ECG subset from 0.74 (0.70 to
0.79) to 0.78 (0.74 to 0.82). However, risk stratified
cumulative probabilities of the primary end point at one
year and six years for all three prognostic indices (clinical
assessment only; clinical assessment plus resting ECG;
clinical assessment plus resting ECG plus exercise ECG)
showedonlysmalldifferencesatalltimepointsandatall
levels of risk.
ConclusionInambulatorypatientswithsuspectedangina,
basic clinical assessment encompasses nearly all the
prognostic value of resting ECGs and most of the
prognosticvalueofexerciseECGs.Thelimitedincremental
value of these widely applied tests emphasises the need
for more effective methods of risk stratification in this
group of patients.
INTRODUCTION
Angina is the most common initial manifestation of
coronary artery disease, with an estimated annual
incidence of 2 per 100 population, higher than that for
myocardial infarction and other acute coronary
syndromes.
1 Prompt assessment, early after presenta-
tion, is important to determine the likelihood of
coronary artery disease and to identify those patients
atriskofadversecardiacoutcomes.
23Forthesereasons
rapid access chest pain clinics were identified as a
management standard within the national service
framework, with the recommendation that all patients
with new onset, stable chest pain should receive
specialist assessment within two weeks of referral.
2
Risk seems higher in patients with new onset angina
than in those with chronic angina and extends into
patientswithadiagnosisofnon-cardiacchestpain,who
accounted for almost one third of cardiac events in a
recent study.
45 No randomised trials of management
strategies in new onset angina have been carried out,
however, with most evidence derived from studies in
patientswithangiographicdocumentationofcoronary
artery disease or with previous myocardial
infarction.
6-8
It is generally accepted that the character of the
symptoms in patients with suspected angina is central
to clinical diagnosis and risk assessment.
9-11 By
convention a resting electrocardiogram (ECG) is
recordedandoftenanexerciseECG,whichisaroutine
investigation in 59% of the chest pain clinics in the
United Kingdom
12 and was part of the initial assess-
ment in 76% of patients with angina in the recent Euro
heartsurvey.
13Whethertheseinvestigationscontribute
incrementally to risk assessment in this group is
unknown, as previous studies have focused on cost
andfeasibilityratherthanonprognosticvalue.
14Other
studies of prognostic value have been subject to
selection bias through inclusion of patients with
previous myocardial infarction or angiographic doc-
umentation of coronary disease,
15-20 and many have
restricted analysis to patients without symptoms.
21-23
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recent onset of suspected angina, none of whom had
been previously assessed for cardiovascular disease.
We identified clinical predictors of coronary events
during long term follow-up and determined whether
resting ECGs and exercise ECGs provide prognostic
value that is incremental to that obtained from the
clinical history.
METHODS
Overall, 8176 of 10634 consecutive patients with new
onset of chest pain referred by their doctor to six chest
painclinicsfrom1January1996to31December2002
were included in this study (fig 1). Fifty one per cent
wereseenwithin72hoursofreferralandafurther46%
within two weeks. We excluded patients without chest
pain, patients with previously diagnosed coronary
artery disease (n=858), patients with incomplete data
on prespecified covariates (n=685), patients not traced
by central registries (n=40),
2425 and patients whose
ethnicity was black or not specified (n=875). From
among these 8176 patients (cohort), a total of 4873
(60%) who had an exercise ECG recorded were
stratified into two subsets: 4848 patients with a
summary test result recorded (positive, negative,
equivocal for ischaemia) and 1422 with additional
detailed test data recorded. These groups comprised
thesummaryECGsubsetanddetailedECGsubsetfor
exercise electrocardiography, respectively. The exer-
cise ECG was obtained in all but 7% of patients on the
day of the clinic visit.
Data collection
We systematically recorded data in a customised
database
26 at the time of the clinic visit. Clinical data
Excluded (n=2458):
  Previous coronary artery disease or no chest pain (n=858)
  Incomplete data on prespecified covariates (n=685)
  Not traced by central registries (n=40)
  Black or other ethnic group (n=875)
Excluded (n=3303):
  Exercise electrocardiography not done (n=3219)
  Exercise ECG report incomplete or not available (n=84)
Patients attending chest pain clinics (n=10 634)
Study cohort (n=8176)
Patients with ECG recorded (n=4873)
Summary exercise ECG subset
Exercise ECG result available (n=4848)
Excluded (n=3426):
  Detailed exercise ECG data not available
Detailed exercise ECG subset
Exercise ECG result available (n=1422)
Fig 1 | Patient selection
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0.74 (0.71 to 0.76)
0.73 (0.71 to 0.75)
0.74 (0.72 to 0.76)
0.68 (0.65 to 0.71)
0.71 (0.72 to 0.76)
Area under curve (95% CI) of basic clinical assessment
Area under curve (95% CI) of basic clinical assessment plus resting ECG
Area under curve (95% CI) of basic clinical assessment plus resting ECG plus exercise ECG (either summary or detailed)
0.69 (0.65 to 0.73)
0.71 (0.67 to 0.75) 0.72 (0.66 to 0.79)
0.74 (0.70 to 0.78)
0.74 (0.70 to 0.79)
0.76 (0.72 to 0.80)
0.78 (0.74 to 0.82)
0.69 (0.62 to 0.77)
0.76 (0.70 to 0.82)
Fig 2 | Performance of prognostic indices in cohort, summary exercise electrocardiogram (ECG) subset, and detailed ECG subset in all eligible patients and in
patientswithintermediate probabilityofcoronaryarterydisease.Prognosticindicesarebasedonage,sex,typicality,anddiabetes(basicclinicalassessment);plus
changesinSTsegment,Q waves,andbundlebranch block(basicclinicalassessmentplusrestingECG); plussummaryECGsubset (negative,positive,equivocal),or
diagnostic changes in ST segment and exercise time in detailed ECG subset
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characteranddescriptorsofchestpain,smokingstatus,
history of hypertension, diabetes (treated using insulin
or tablets), pulse rate, systolic blood pressure, treat-
ment, and follow-up plan. At the end of the consulta-
tion we recorded the diagnosis on the basis of the
clinical assessment (angina, non-cardiac chest pain,
other). We obtained a resting 12 lead ECG for every
patient,recordedasnormalorabnormaldependingon
entries in the database for rhythm, conduction,
regional change in ST segment or T wave, left
ventricular hypertrophy, and Q waves. Treadmill
stress testing was undertaken according to perceived
clinicalneedusingtheBruceprotocol,withcontinuous
monitoring of blood pressure, heart rate, and ECG up
to five minutes into recovery. In the summary ECG
subsetonlytheclinicians’assessmentofischaemiawas
recorded (positive, negative, or equivocal). In the
detailed ECG subset, data recorded included exercise
time, maximum workload, maximum heart rate,
maximum blood pressure, diagnostic change in ST
segment, arrhythmias, and reason for stopping (limit-
ing symptoms,STsegmentdisplacement ofmore than
1mm0.08secondsaftertheJpoint,ortargetheartrate
achieved).
Follow-up and main outcome measure
We flagged the patients up to 23 December 2003 for
mortality with the Office for National Statistics
24 and
for hospital admissions and procedures with Second-
ary Uses Service,
25 with successful matching in 99.5%
ofcases.Alloutcomesweredefinedbycodesaccording
to the World Health Organization international
classification of diseases, 10th revision.
27 We used the
primary discharge diagnosis to define events among
patients undergoing hospital admission during the
follow-up period.
Theprimaryendpointwasacompositeofdeathdue
to coronary heart disease (code I20-I25) or non-fatal
acute coronary syndrome (I20-I23, 124.0, I24.8,
I24.9).
27
Statistical analysis
We used Stata version 8.0 for all analyses. We
compared the characteristics of the patients in the
whole cohort with those in the ECG subsets. Data on
patients who underwent coronary artery bypass graft-
ing (code K40-K46) or percutaneous coronary inter-
vention (K49-K50.9) were censored at the time of the
revascularisation procedure because of its potential to
affect prognosis. Firstly, we carried out multivariable
Cox analysis for the primary end point using factors
that were statistically significant at the 20% level in
univariable analysis for each of three separate models:
clinical model (age, sex, typicality of symptoms, heart
rate, systolic blood pressure, history of hypertension,
diabetes, smoking status), ECG model (QRS axis
deviation,pathologicalQwaves,changeinSTsegment
orTwave,leftventricularhypertrophy,bundlebranch
block), summary exercise ECG model (positive,
negative, or equivocal), and detailed exercise ECG
model(exercisetime,maximumworkload,percentage
predictedheartrate,maximumbloodpressure,reason
forstoppingexercise,diagnosticchangeinSTsegment,
exertional arrhythmias). We then used the covariates
that remained statistically significant at the 5% level in
each model to build three incremental models: basic
clinical assessment, basic clinical assessment plus
restingECG,and basicclinicalassessmentplusresting
ECG plus either summary exercise ECG or detailed
exercise ECG. Then we calculated prognostic indices
foreachoftheincrementalmodelsusingtheregression
Table 1 |Clinical characteristics of cohort with suspected angina and subsets with summary
exercise ECGs and detailed exercise ECGs recorded. Values are numbers (percentages) of
participants unless stated otherwise
Variables
Whole cohort
(n=8176)
Summary ECG
subset (n=4848)
Detailed ECG subset
(n=1422)
Mean (SD) age (years) 55 (13) 55 (13) 54 (11)
Character of chest pain:
Typical 1939 (24) 1405 (29) 346 (24)
Atypical 4785 (59) 3061 (65) 989 (70)
Non-specific 1452 (18) 382 (8) 87 (6)
Male 4349 (53) 2802 (58) 824 (58)
Ethnicity:
White 5904 (72) 3640 (75) 877 (62)
South Asian 2272 (28) 1208 (25) 545 (38)
Risk factors for cardiovascular disease:
Current smoker 2033 (25) 1295 (27) 350 (25)
Hypertension 2783 (34) 1659 (34 ) 472 (33)
Diabetes 850 (10) 531 (11) 190 (13)
Mean(SD)systolicbloodpressure(mm
Hg)
141 (21) 140 (20) 138 (20)
Mean (SD) heart rate (beats/min) 77 (12) 76 (12) 76 (12)
Drugs on admission*:
Aspirin 1667 (21) 1177 (24) 213 (15)
β blocker 1199 (15) 815 (17) 183 (13)
Calcium blocker 872 (11) 492 (10) 125 (9)
Statin 887 (11) 647 (14) 126 (9)
Resting 12 lead ECG:
Abnormal 1412 (17) 713 (15) 209 (15)
Frontal QRS axis deviation 174 (2) 99 (2) 50 (4)
Bundle branch block 266 (3) 94 (2) 34 (2)
Q waves 156 (2) 80 (2) 20 (1)
Change in ST segment or T wave 771 (9) 417 (9) 111 (8)
Left ventricular hypertrophy 263 (3) 121 (3) 27 (2)
Probability of coronary artery disease:
<20% 1730 (21) 578 (12) 177 (13)
20-80% 4852 (59) 3148 (65) 982 (69)
>80% 1594 (20) 1122 (23) 263 (19)
Death from coronary heart disease or
acute coronary syndrome
576 (7) 351 (7) 110 (8)
Death from coronary heart disease 104 (1) 51 (1) 12 (1)
Acute coronary syndrome 501 (6) 312 (6) 102 (7)
Coronary angiogram 979 (12) 708 (15) 186 (13)
PTCA 236 (3) 190 (4) 56 (4)
CABG 242 (3) 173 (4) 35 (3)
PTCA or CABG 465 (6) 354 (7) 87 (6)
PTCA=percutaneous transluminal coronary angioplasty; CABG=coronary artery bypass grafting.
*Data were not complete for cohort.
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basic clinical model and the resting ECG model in the
wholecohortandusedthesummaryanddetailedECG
subsets to develop the models that include data on the
exercise ECG. We forced the variables from the basic
clinical model and the resting ECG model into the
models with data on the exercise ECGs. We plotted
receiver operating characteristics curves and calcu-
lated the C statistic with confidence intervals for each
prognostic index
28 to examine the incremental prog-
nostic value of the resting ECG and exercise ECG.
Curves were plotted for all patients and for patients
with intermediate probability of coronary artery
disease(20-80%),basedontheDiamondandForrester
algorithm, which takes into account age, sex, and
typicalityofchestpain.
29Finally,wearbitrarilysplitthe
prognostic index into thirds for risk
30 and charted the
probabilitiesofdevelopinganeventatoneyearandsix
years to illustrate the incremental value of the resting
ECG and exercise ECG for each risk category during
long term follow-up.
RESULTS
Participantsinthewholecohortwerefollowed-upfora
median2.46years(interquartilerange1.61-3.92years),
inthesummaryECGsubsetfor2.21(1.27-3.26),andin
the detailed ECG subset for 2.26 (1.51-5.18). Partici-
pants in each of the subsets had broadly similar
characteristics to the cohort except for a greater
proportion of patients with atypical symptoms and an
intermediate probability of coronary artery disease
(table 1). Angina was diagnosed in 29% of the cohort,
32% of the summary ECG subset, and 28% of the
detailed ECG subset.
Covariate screening and prognostic indices
Table 2liststhecovariatespreselectedformultivariate
modelling. In the basic clinical assessment model the
variablesoftypicalchestpain,age,diabetes,andbeing
male were independently associated with an increased
risk of the composite end point of death due to
coronary heart disease or non-fatal acute coronary
syndrome. In the resting ECG model, variables
independently associated with an increased risk of the
primary end point were bundle branch block, change
inSTsegmentorTwave,andQwaves.Inthesummary
exercise ECGmodel the resultwas associatedwith the
primary end point, and in the detailed exercise ECG
model the variables independently associated were
exercise time and change in the ST segment on
exertion.
Table 3showstheresultsoftheincrementalmodels.
In the final iterations (clinical assessment plus resting
ECGplusexerciseECG) themajor contributorstothe
risk of the primary end point were typical symptoms
and abnormalities on the exercise ECG, with age, sex,
and diabetes making variable additional contributions
depending on whether the summary ECG subset or
detailed ECG subset was analysed.
Receiver operating characteristics curves and C statistic
In the cohort,receiveroperatingcharacteristics curves
for the basic clinical assessment model alone and with
iteration for the resting ECG were effectively super-
imposed with little or no increment in the C statistic
(fig 2). With the iterations for the exercise ECGs the C
statistic for the basic clinical assessment model
increased in the summary ECG subset from 0.70
(95% confidence interval 0.68 to 0.73) to 0.74 (0.71 to
0.76)andinthedetailedECGsubsetfrom0.74(0.70to
0.79) to 0.78 (0.74 to 0.82). When analysis was
restricted to patients with an intermediate probability
of coronary artery disease (20-80%), the receiver
operating characteristics curves for the basic clinical
assessment model alone and with iteration for the
resting ECG remained effectively superimposed,
Table 2 |Unadjusted and adjusted hazard ratios for death from coronary heart disease or non-
fatal acute coronary syndrome in three models: basic clinical assessment, resting
electrocardiogram (ECG), and exercise ECG
Covariate
Univariable hazard
ratio (95% CI)
P
value
Adjusted hazard
ratio* (95% CI)
P
value
Whole cohort (n= =8167) risk of composite end point† † (events= =576)
Basic clinical assessment:
Age (10 year increase) 1.04 (1.03 to 1.05) <0.001 1.02 (1.02 to 1.03) <0.001
Sex (female v male) 0.75 (0.64 to 0.88) <0.001 0.76 (0.65 to 0.90) <0.001
Typicality
Typical v atypical 3.94 (3.33 to 4.67)
<0.001
3.17 (2.66 to 3.79)
<0.001
Non-specific v atypical 0.61 (0.45 to 0.83) 0.68 (0.50 to 0.93)
Heart rate per 10 second increase 0.98 (0.92 to 1.05) 0.53 NA NA
Systolic blood pressure 1.10 (1.06 to 1.14) <0.001 1.02 (0.98 to 1.06) 0.313
Hypertension 0.71 (0.61 to 0.84) <0.001 1.01 (0.85 to 1.21) 0.870
Diabetes 1.90 (1.55 to 2.32) <0.001 1.48 (1.20 to 1.83) <0.001
Current smoker 1.04 (0.86 to 1.25) 0.71 NA NA
Resting ECG:
Abnormal axis 2.25 (1.53 to 3.31) <0.001 1.40 (0.94 to 2.08) 0.12
Q waves 3.73 (2.67 to 5.23) <0.001 2.62 (1.85 to 3.70) <0.001
Change in ST segment or T wave 2.77 (2.29 to 3.35) <0.001 2.43 (1.98 to 2.98) <0.001
Left ventricular hypertrophy 1.72 (1.23 to 2.40) 0.0032 1.09 (0.77 to 1.54) 0.63
Bundle branch block 2.18 (1.57 to 3.02) <0.001 1.96 (1.40 to 2.73) <0.001
Summary ECG subset (n= =4848), (events= =351)
Exercise ECG:
Positive result v negative result 4.58 (3.68 to 5.72)
<0.001 NA NA
Equivocal v negative result 2.16 (1.48 to 3.14)
Detailed ECG subset (n= =1422), (events= =110)
Exercise ECG:
Exercise time (minutes) 0.80 (0.75 to 0.86) <0.001 0.84 (0.77 to 0.93) 0.0025
Maximum workload 0.84 (0.79 to 0.90) <0.001 0.99 (0.93 to 1.07) 0.87
% predicted heart rate 0.99 (0.98 to 1.00) 0.0078 0.99 (0.98 to 1.00) 0.25
Maximum blood pressure 1.00 (0.99 to 1.01) 0.66 NA NA
Reason for stopping*:
Non-cardiac v target heart rate 1.95 (1.02 to 3.74)
<0.001
1.48 (0.75 to 2.93)
0.28
Cardiac v target heart rate 4.10 (2.15 to 7.81) 1.72 (0.85 to 3.45)
Diagnostic change in ST segment 4.48 (3.06 to 6.55) <0.001 3.28 (2.18 to 4.93) <0.001
Arrhythmias 1.37 (0.82 to 2.29) 0.25 NA NA
NA=not applicable.
*Adjusted for variables significant at 20% level in univariable analysis: non-cardiac (leg pain, fatigue, dizziness,
other) and cardiac (chest pain, shortness of breath, change in ST segment, arrhythmia, abdominal pain).
†Death from coronary heart disease or non-fatal acute coronary syndrome.
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iterations the C statistic (95% confidence interval) for
the basic clinical assessment model increased in the
summary ECG subset from 0.69 (0.65 to 0.73) to 0.74
(0.70to0.78)andinthedetailedECGsubsetfrom0.69
(0.62 to 0.77) to 0.76 (0.70 to 0.82).
Patient outcomes
Typical chest pain and abnormalities on the resting
ECG and exercise ECG were all associated with
adverse outcomes (table 4). Thus point estimates of
the probability of the primary end point at three years
were 16% for patients with typical chest pain, 15% for
patients with an abnormal resting ECG, and 19% for
patients with an abnormal exercise ECG, compared
with 3%, 5%, and 9% for patients with non-specific
chest pain and normal resting and exercise ECGs.
However, 47% (n=166) of the events during follow-up
occurred in patients with a “normal” exercise ECG,
emphasising the limitations of ECGs for risk assess-
ment.ThusinboththesummaryECGandthedetailed
ECGsubsets,riskstratifiedcumulativeprobabilitiesof
the primary end point at one year and six years for all
three prognostic indices (basic clinical assessment,
basic clinical assessment plus resting ECG, basic
clinical assessment plus resting ECG plus exercise
ECG) showed only small differences at all time points
and in all thirds of risk (table 5).
DISCUSSION
In ambulatory patients with suspected angina, the
clinical assessment embraces nearly all the prognostic
informationprovidedbytherestingelectrocardiogram
(ECG) and exercise ECG. The limited incremental
value of these widely applied non-invasive investiga-
tionsextendedacrossallthirdsofrisk,emphasisingthe
importance of the clinical assessment and the need for
more effective methods of risk stratification in this
group of patients.
In patientswithundifferentiated chestpainthereisa
gradient of coronary risk, greatest in those with a
diagnosis of angina but extending to those with a
diagnosis of non-cardiac chest pain.
5 The importance
of a careful history is widely acknowledged. Our
patientswithtypicalangina,similartothosereportedin
a previous study,
31 were at higher risk of adverse
outcomes than patients with atypical symptoms.
Experience of non-invasive testing in patients with
undifferentiated chest pain has increased in recent
years, but uncertainty about its value for risk assess-
mentremains.
14Wefoundthatarangeofabnormalities
in both the resting ECG and the exercise ECG were
independently predictive of adverse events in ambu-
latory patients with chest pain of recent onset. It is
salutarytonote,however,that47%ofalleventsduring
follow-upoccurredinpatientswitha negativeexercise
ECGresult,emphasisingthelimitationsofusingECGs
for risk assessment, and reminding us that the
demonstration of a test’s independent prognostic
value does not imply clinical utility if it is not
incremental to information obtained more simply
from the history and examination. In this respect our
findings were unequivocal, particularly for the resting
ECG, which showed no incremental prognostic value
above that of the clinical assessment. For the exercise
ECGs, incremental prognostic value seemed some-
what greater as reflected in point estimates for the C
statistic,whichincreasedby5.7%fortheexerciseECG
Table 3 |Adjusted hazard ratios for three incremental models: basic clinical assessment, basic
clinical assessment plus resting electrocardiogram (ECG), and basic clinical assessment plus
resting ECG plus exercise ECG
Covariate Coefficient
Adjusted hazard ratio
(95% CI) P value
Clinical assessment with significant variables (cohort)
Age (10 year increase) 0.26 1.30 (1.21 to 1.39) <0.001
Sex (female v male) −0.28 0.75 (0.64 to 0.89) 0.0008
Typicality of chest pain:
Typical v atypical 1.13 3.09 (2.58 to 3.71)
<0.001
Non-cardiac v atypical −0.38 0.68 (0.50 to 0.93)
Diabetes 0.45 1.58 (1.28 to 1.94) <0.001
Clinical assessment plus resting ECG (cohort)
Age (10 year increase) 0.23 1.26 (1.17 to 1.35) <0.001
Sex (female v male) −0.27 0.76 (0.65 to 0.90) 0.0013
Typicality of chest pain:
Typical v atypical 1.04 2.82 (2.34 to 3.40
<0.001
Non-cardiac v atypical −0.37 0.69 (0.50 to 0.95)
Diabetes 0.41 1.50 (1.22 to 1.86) 0.0002
Q waves 0.57 1.77 (1.24 to 2.53) 0.0037
Bundle branch block 0.30 1.36 (0.95 to 1.94) 0.1089
Change in ST segment or T
wave
0.45 1.57 (1.28 to 1.94) <0.001
Clinical assessment plus resting ECG plus summary exercise ECG*
Age (10 year increase) 0.10 1.11 (1.00 to 1.22) 0.048
Sex (female v male) −0.05 0.95 (0.76 to 1.18) 0.64
Typicality of chest pain:
Typical v atypical 0.75 2.12 (1.66 to 2.71)
<0.001
Non-cardiac v atypical −0.54 0.58 (0.29 to 1.19)
Diabetes 0.36 1.44 (1.09 to 1.89) 0.0134
Q waves 0.75 2.12 (1.28 to 3.49) 0.051
Bundle branch block −0.11 0.90 (0.40 to 2.02) 0.79
Change in ST segment or T
wave
0.29 1.34 (1.01 to 1.79) 0.0078
Positive v negative exercise
ECG
0.92 2.53 (1.95 to 3.30)
<0.001
Equivocal v negative exercise
ECG
0.44 1.55 (1.06 to 2.28)
Clinical assessment plus resting ECG plus detailed exercise ECG*
Age (10 year increase) 0.03 1.03 (0.85 to 1.25) 0.76
Sex (female v male) −0.59 0.55 (0.37 to 0.83) 0.0036
Typicality of chest pain:
Typical v atypical 0.90 2.45 (1.62 to 3.70)
<0.001
Non-cardiac v atypical −0.52 0.59 (0.14 to 2.45)
Diabetes 0.03 1.03 (0.63 to 1.70) 0.9023
Q waves 0.49 1.64 (0.64 to 4.18) 0.3338
Bundle branch block 0.42 1.53 (0.48 to 4.89) 0.5022
Change in ST segment or T
wave
0.32 1.37 (0.83 to 2.27) 0.2264
Exercise time (minutes) −0.15 0.86 (0.79 to 0.93) 0.0005
Diagnostic change in ST
segment
0.81 2.26 (1.44 to 3.53) 0.0005
*Covariates were those selected in whole cohort.
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exercise ECG subset with more detailed results.
Increaseswereonlymarginallygreateramongpatients
with an intermediate probability of coronary artery
disease, the group in which the exercise ECG is most
usefulfordiagnostic purposes.
32Howtointerpretsuch
changesintheCstatistichasbeendebated.
33Inclinical
terms the incremental prognostic value was trivial (see
table 5), with the indices that incorporated data from
theexerciseECGprovingnomoreeffectivethanthose
of the basic clinical assessment in predicting adverse
outcomes.Importantly,detailedanalysisofvariablesin
the exercise ECG performed little better than the
summaryassessmentthatiscommonlyusedin clinical
practice.
Previous studies of treadmill testing in chest pain
clinic populations have been small and, although
confirming feasibility and safety, have not been
powered to test prognostic value.
14 Before these
studies,astudy
15haddevelopedaprognostictreadmill
score in a group of patients referred for cardiac
catheterisation, which has since been validated in
outpatient populations.
16 Both development and vali-
dation groups in these studies contrasted with our
patients, however, being predominantly male, often
with a history of myocardial infarction and other
manifestations of bias from investigations owing to
their selection from patients referred for cardiac
catheterisation. Application of this score to patients
with chest pain of recent onset in chest pain clinics
therefore requires caution. Nevertheless, the incre-
mentalvalueofthescoreforpredictingsurvivalatfour
years in an outpatient population was modest and
similar to our exercise ECG model.
16 In another study
the increment in the C statistic was similarly modest
when the treadmill score was added to the clinical
assessment model.
18 More recently, prognostic scores
by the ACTION trialists
34 and Euro heart
investigators
35 have been presented, but these scores
utilisedatanotalwaysavailableatfirstpresentationand
applytopatientswithchronicstableangina,manywith
a history of myocardial infarction and whose risk
characteristics are different from the patients with
suspected angina in the present study.
The methods in this study are robust and reflect the
incremental value of the different statistical models
ratherthansimplecomparisonoflikelihoodratios.We
excluded only 7% of patients (n=725) because of
missing data or not being traced by central registries.
This is unlikely to have affected our conclusions
because outcomes in this group were not significantly
different from those included in our study. Important
limitationswere the absenceofdata onlipid levelsand
family history, although had these been available they
would probably have improved the discriminatory
power of the clinical model and would not therefore
have affected our conclusions. Similarly, our conclu-
sions would not have been affected by exclusionof the
167patients(2%)withQwaves,suggestingahistoryof
silent infarction, because this would have further
reduced the prognostic value of the resting ECG. An
Table 4 |Cumulative probability of composite end point of death from coronary heart disease or
non-fatal acute coronary syndrome at one year and six years in patients with suspected angina
Variable
% cumulative probability of end point (95% CI)
1 year 6 years
Character of chest pain:
Non-specific 1 (0 to 1) 3 (2 to 4)
Atypical 2 (2 to 3) 5 (4 to 5)
Typical 8 (7 to 10) 16 (14 to 18)
Resting ECG:
Normal 3 (2 to 3) 5 (5 to 6)
Abnormal 7 (6 to 8) 15 (13 to 17)
Exercise ECG (n=4848):
Normal 2 (2 to 4) 9 (6 to 14)
Equivocal 4 (2 to 6) 18 (12 to 27)
Abnormal 4 (2 to 6) 19 (16 to 23)
ECG=electrocardiogram.
Table 5 |Cumulative probabilities of an event according to three prognostic indices in cohort and in exercise electrocardiogram (ECG) subsets
Risk groups
% cumulative probability (95% CI) at 1 year % cumulative probability (95% CI) at 6 years
Clinical
assessment
Clinical assessment plus
resting ECG
Clinical assessment plus
resting ECG plus exercise
ECG* Clinical assessment
Clinical assessment plus
resting ECG
Clinical assessment
plus resting ECG plus
exercise ECG*
Cohort:
Low 1 (0 to 1) 1 (0 to 1) NA 4 (3 to 6) 4 (3 to 6) NA
Medium 2 (2 to 3) 1 (1 to 2) NA 10 (8 to 12) 8 (7 to 11) NA
High 7 (6 to 8) 8 (7 to 9) NA 25 (22 to 28) 27 (23 to 30) NA
Summary ECG subset:
Low 1 (1 to 2) 0 (1 to 2) 1 (1 to 2) 5 (3 to 8) 5 (3 to 8) 5 (3 to 8)
Medium 2 (2 to 3) 3 (2 to 3) 3 (2 to 3) 11 (9 to 15) 11 (8 to 14) 11 (8 to 14)
High 8 (6 to 9) 8 (6 to 9) 8 (6 to 9) 23 (20 to 27) 24 (21 to 29) 24 (21 to 27)
Detailed ECG subset:
Low 0 (0 to 2) 0 (0 to 1) 0 (0 to 1) 5 (3 to 10) 3 (1 to 7) 3 (1 to 8)
Medium 2 (1 to 4) 2 (1 to 4) 3 (2 to 5) 8 (5 to 13) 9 (6 to 14) 9 (6 to 14)
High 8 (6 to 10) 8 (6 to 11) 7 (5 to 10) 21 (16 to 26) 22 (17 to 28) 22 (17 to 28)
NA=not applicable.
*Either incremental summary exercise ECG or detailed exercise ECG depending on subset.
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revascularisation, which in turn might influence
prognosis. A sensitivity analysis using coronary artery
bypass grafting as part of the composite end point did
not, however, change the findings. We did not capture
the exact magnitude of change in the ST segment
during the exercise test, but this is not a serious
limitation for prognostic assessment. The presence of
such change is indicative of ischaemia but may not
correlate with coronary anatomy,
3637 and agreements
on changes in the ST segment can vary between
observers. One of the most consistent prognostic
markers in exercise testing is maximum exercise
capacity,
32 the specific variable (maximum duration
of exercise, level of metabolic equivalents achieved,
maximum workload, maximum heart rate, double
product) used to summarise this being less important.
The prognostic importance of age is not undermined
by its lack of significance in the final incremental
model, which merely indicates that in patients under-
going exercise testing, more prognostic weight is
contributed by exercise time, the presence of change
in the ST segment, and typical chest pain.
In conclusion, our study emphasisesthe importance
oftheclinicalassessmentforprognosisinpatientswith
suspected angina. The data show that the need to
improveriskstratificationcannotbemetbytheresting
ECG whereas the incremental value of the exercise
ECG is small. Alternative tests are needed but must be
developed within cohorts from chest pain clinic
because prognostic value depends on the population
inwhichthetestisapplied.
38Aprerequisiteofanynew
test should be the demonstration of its incremental
value over clinical assessment if risk stratification is to
be improved and the potential for chest pain clinics to
reduce coronary mortality is to be fully realised.
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